This study found that needle-free insulin injection (NFII) significantly improved fasting glucose variability and reduced basal insulin needs compared to conventional pens in type 2 diabetes patients. The results suggest NFII enhances insulin absorption, providing more stable glucose control and potential benefits for diabetes management.

This study found that needle-free insulin syringes effectively controlled fasting blood glucose in early-onset type 2 diabetes patients while causing less pain and fewer skin reactions than conventional pens. The findings suggest they may improve patient well-being, compliance, and overall diabetes management.

This study found that the QS-M needle-free jet injector delivered insulin lispro with faster absorption and a stronger early glucose-lowering effect than conventional pens, closely mimicking natural insulin secretion. Despite the quicker action, overall insulin exposure was similar, and no local adverse reactions were observed, supporting its effectiveness and safety.

This study found that the QS-M needle-free jet injector delivered insulin lispro with faster absorption and a stronger early glucose-lowering effect than conventional pens, closely mimicking natural insulin secretion. Despite the quicker action, overall insulin exposure was similar, and no local adverse reactions were observed, supporting its effectiveness and safety.

This study showed that needle-free injection (NFI) of mRNA-LNP COVID-19 vaccines produced stronger immune responses, with higher neutralizing antibody levels, than traditional needle injection. NFI also reduced pain, maintained vaccine stability, allowed flexible administration routes, and supported split-dose delivery, making it a safe and effective alternative for vaccination.